Objectives: To re-examine interhospital variation in 30 day survival after acute myocardial infarction (AMI) 10 years on to see whether the appointment of new cardiologists and their involvement in emergency care has improved outcome after AMI. Design: Retrospective cohort study. Setting: Acute hospitals in Scotland. Participants: 61 484 patients with a first AMI over two time periods: 1988-1991; and 1998-2001. Main outcome measures: 30 day survival. Results: Between 1988 and 1991, median 30 day survival was 79.2% (interhospital range 72.1-85.1%). The difference between highest and lowest was 13.0 percentage points (age and sex adjusted, 12.1 percentage points). Between 1998 and 2001, median survival rose to 81.6% (and range decreased to 78.0-85.6%) with a difference of 7.6 (adjusted 8.8) percentage points. Admission hospital was an independent predictor of outcome at 30 days during the two time periods (p , 0.001). Over the period 1988-1991, the odds ratio for death ranged, between hospitals, from 0.71 (95% confidence interval (CI) 0.58 to 0.88) to 1.50 (95% CI 1.19 to 1.89) and for the period 1998-2001 from 0.82 (95% CI 0.60 to 1.13) to 1.46 (95% CI 1.07 to 1.99). The adjusted risk of death was significantly higher than average in nine of 26 hospitals between 1988 and 1991 but in only two hospitals between 1998 and 2001. Conclusions: The average 30 day case fatality rate after admission with an AMI has fallen substantially over the past 10 years in Scotland. Between-hospital variation is also considerably less notable because of better survival in the previously poorly performing hospitals. This suggests that the greater involvement of cardiologists in the management of AMI has paid dividends.
I n a study of the period 1988 to 1991, substantial variation in 30 day survival after admission with acute myocardial infarction (AMI) was identified between hospitals in Scotland. 1 Since that study, at least one cardiologist has been appointed in each Scottish hospital and acute medical care has been reorganised in most to ensure more rapid and appropriate care of patients suspected to have this diagnosis. 2 We have re-examined variation in survival after admission with AMI 10 years after the initial study. Our aim was to determine whether there has been a reduction in the variation in survival between Scottish hospitals in this more recent time period compared with the earlier one.
METHODS

Data sources
A Scotland-wide retrospective study was carried out by using the linked Scottish Morbidity Record (SMR) database. 3 Data on all National Health Service (NHS) hospital discharges in Scotland (total population about 5.1 million) are collected (on the SMR 1 form) and collated by the Information and Statistics Division (ISD) of the NHS. Linking records through probability matching (with an accuracy of about 98%) permits analysis of data at the level of the individual patient rather than the episode of care. This database is also linked to that of the Registrar General for death certificates (also with an estimated accuracy of 98%). For any given patient, therefore, readmission after an index hospitalisation can be tracked (and the nature of the readmission identified). Patients' deaths are also recorded. 3 We identified all patients discharged (alive or dead) from Scottish hospitals during two periods of time-between October 1988 and September 1991, and between October 1998 and September 2001-with a principal diagnosis of AMI (International classification of diseases (ICD), ninth revision code 410 and ICD-10 codes I21 and I22). 4 Only discharges for a ''first'' AMI were analysed. A first AMI was defined as one where the patient had no prior hospital discharge for AMI. Only hospitals admitting patients with emergency medical problems during both study periods (n = 26) were compared in this analysis.
Quality of data
The Quality Assessment and Accreditation Unit of ISD routinely validates a 1% sample of SMR 1 records (where SMR 1 data are compared with those in each patient's medical record). The accuracy of AMI coded as a principal diagnosis has been shown to be 97%. 5 The accuracy of coding secondary conditions is 75%. 6 Baseline data Each patient's SMR 1 record provided information on age, sex, postcode sector, date of discharge, hospital discharge from, previous discharges, and date of death if it occurred. Postcodes of residence were used to assign a Carstairs deprivation category ranging from 1 (least deprived) to 5 (most deprived) to each patient. 7 These categories are derived from the 1991 census data on the proportion of residents who are unemployed, live in overcrowded accommodation, do not have a car, or belong to a low occupational social class. There is a strong concordance between Carstairs scores for postcode sectors in 1991 and 2001 (Pearson's correlation coefficient r = 0.955). 8 All prior discharges within five years were identified by retrospective linkage. Secondary conditions on the index admission allowed the identification of up to five comorbidities.
Statistical analysis
Baseline characteristics of patients admitted to hospital within the two time periods were compared by x 2 test for discrete variables and Student's t test for continuously distributed variables. Crude 30 day survival was calculated for each hospital and for Scotland as a whole by use of the actuarial life table method. Indirect standardisation was then used to adjust hospital specific 30 day survival rates for age and sex differences between the hospital population and the whole Scottish population. Multiple logistic regression models were used to determine the independent effect of hospital on 30 day case fatality after adjusting for the effects of age, sex, deprivation category, and prior and concurrent morbidities. The hospitals were entered into the logistic models as one categorical variable. The ''index'' hospital was set as that with a case fatality nearest the Scottish crude case fatality for that time period. All variables were entered simultaneously into the models. Each model was subject to the Hosmer-Lemeshow goodness of fit test, and all were nonsignificant. All analyses were undertaken with use of SPSS version 11 (SPSS Inc, Chicago, Illinois, USA). Table 1 shows the baseline characteristics of the 61 484 patients discharged with a first AMI during the two time periods of study: 36 108 (58.7%) were admitted between 1988 and 1991 and 25 376 (41.3%) were admitted between 1998 and 2001. The mean age of men and women increased between these time periods (p , 0.001). In the period 1988-1991, 48.2% of men were aged 65 or over. Thirty day survival after hospital admission Table 2 shows improved crude and age and sex adjusted 30 day survival. Crude 30 day survival for first AMI increased from 77.7% in 1988-1991 to 80.9% in 1998-2001 in Scotland as a whole. The number of hospitals with a 30 day survival of less than 75% decreased from five to none (and those with a survival of less than 80% from 18 to seven) between these two periods. Between 1998 and 2001 the median crude 30 day survival rate was 81.6% with a range from 78.0% to 85.6%. This difference of 7.6 percentage points increased slightly to 8.8 percentage points after standardising for age and sex. Therefore, the interhospital variability decreased between these two time periods after adjustment for age and sex differences. The hospitals with the worst survival in 1988-1991 improved the most.
RESULTS
Baseline characteristics
Multiple logistic regression
1988-1991
After adjustment for age, sex, deprivation category, and prior (previous admissions) and concurrent morbidities (secondary discharge diagnoses), admission hospital was a highly significant predictor of outcome at 30 days (p , 0.001). *Data are mean (median); Àprimary or secondary discharge diagnosis in the previous five years or secondary discharge coding at time of admission with index myocardial infarction;`includes influenza, pneumonia, and chronic lower respiratory diseases. CHD, coronary heart disease.
The odds ratio for death after admission with AMI ranged from 0.71 (95% confidence interval (CI) 0.58 to 0.88) to 1.50 (95% CI 1.19 to 1.89) between hospitals. The index hospital was hospital 18, which had the same crude survival as Scotland as a whole (fig 2A) . The adjusted risk of death within 30 days after an admission with AMI was significantly higher than average in nine (and better in one) of 26 hospitals.
1998-2001
Admission hospital remained an independent predictor of outcome at 30 days (p , 0.001). The odds ratio for death ranged from 0.82 (95% CI 0.60 to 1.13) to 1.46 (95% CI 1.07 to 1.99) between hospitals relative to hospital 9, which had a crude survival similar to that of Scotland as a whole ( fig 2B) . Interhospital variation was less and the adjusted risk of death was significantly higher than average in only two hospitals.
DISCUSSION
There are two notable findings of this study. Firstly, despite an increase in age and documented co-morbidity, patients with AMI had a higher 30 day survival in Scotland between 1998 and 2001 than in the period 1988 to 1991. Secondly, and most germane to the aims of this study, interhospital variation has declined substantially between 1988 and 1991 and between 1998 and 2001. Though not the principal aim of this study, it was of interest to be able to confirm that there has been a fall in the incidence of AMI between the two study periods, a finding consistent with prior studies from Scotland and elsewhere. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] This may be attributable to a variety of factors including better primary prevention, falling rates of smoking, a change in the natural history of coronary artery disease, and better public and doctor awareness of the importance of potential cardiac symptoms. Similarly, the increase in 30 day survival after an AMI is also consistent with prior reports from Scotland and elsewhere. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Several factors, including those that may have contributed to the decline in incidence, may be important. 20 Others are changing thresholds for referral (whereby patients with chest pain are more likely to be referred to hospital by primary care practitioners) and admission (when referred patients are more likely than previously to be admitted). Diagnostic thresholds may also have been lowered, with consequent changes in severity of infarction. New treatments may also have played an important part.
The second major finding of this study (and the one most pertinent to the aim of the study) is that interhospital variation has declined substantially between 1988-1991 and 1998-2001 . This is less easy to attribute to the factors mentioned above in connection with the decline in case fatality between these two periods. Indeed, our hypothesis was that greater input of cardiologists and reorganisation of care should have led to less between-hospital variation in 30 day survival and our findings are consistent with this (these factors may also, of course, have contributed to the improvement in survival).
The reduction in variation between hospitals seemed to be due, substantially, to a particularly notable improvement in survival in those hospitals that had the highest care fatality in the 1988-1991 study.
Though there was less variation between 1998 and 2001 than previously, interhospital variation persisted, with a nine percentage point difference in adjusted survival. The reasons for this require further study, as identification of correctable factors (such as deficiencies in treatment) may lead to further improvements in outcome and reductions in variation. This highlights the major limitation of this study, which is the absence of information on treatment and on other factors such as measurement of ventricular function, which may allow better adjustment of case mix.
In summary, the appointment of cardiologists and their involvement in the care of acute admissions to Scottish hospitals seem to be associated with an overall improvement (and less variation between hospitals) in survival after AMI. A paclitaxel coated stent used for in-stent restenosis within a sirolimus coated stent fails to protect against recurrent restenosis T he optimal approach to in-stent restenosis (ISR) within a drug eluting stent (DES) remains uncertain. The Rotterdam research registry reported a zero major adverse cardiac event (MACE) rate at a median of 131 days in 10 patients treated with a paclitaxel coated Taxus DES for ISR within a sirolimus coated Cypher DES. However, this strategy may fail to prevent recurrent ISR. A 40 year old exsmoking white female with type 1 diabetes, renal failure, hypertension, hypercholesterolaemia, and a strong family history of premature coronary disease had inferior ischaemia on a myocardial perfusion scan and a 90% stenosis in the right coronary artery at angiography (panel A). This was predilated and stented with a 2. 
